DALLAS, July 21, 2015 /PRNewswire/ --
According to the new market research report The "Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019", published by MarketsandMarkets, the global Vaccines Market is expected to reach $57,885.4 Million by 2019 from $33,140.6 Million in 2014, at a CAGR of 11.8% from 2014 to 2019.
Browse 145 Market Data Tables and 65 Figures spread through 220 Pages and in-depth TOC on "Vaccine Market"
http://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html
Early buyers will receive 10% customization on this report.
The Vaccines Market is fragmented due to the presence of a few big players and several small players. Prominent players in the Vaccines Market include Bavarian Nordic (Denmark), CSL Limited (Australia), Emergent BioSolutions Inc. (U.S.), GlaxoSmithKline, plc. (U.K.), Johnson and Johnson (U.S.), MedImmune, LLC (U.S.), Merck and Company (U.S.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.), and Sanofi Pasteur (France).
Further Inquiry: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1155
GlaxoSmithKline, plc. dominated the Vaccines Market in 2013. The company focuses on both organic as well as well as inorganic growth strategies for enhancing its market position. In April 2014, GlaxoSmithKline signed an agreement with Novartis AG (Switzerland) to acquire the vaccine division of Novartis. This acquisition helped GlaxoSmithKline to become a leader in the Vaccines Market by adding various Novartis vaccine products to its product portfolio. The company is innovation centric and invests heavily in R&D for maintaining its market share. In this regard, in 2013, the company invested $775.2 million in R&D.
The key strategies followed by most companies in the Vaccines Market are acquisitions; regulatory approvals; and agreements, collaborations, and partnerships. The strategy of agreements, collaborations, and partnerships accounted for the largest share of the overall growth strategies mapped from 2012 to 2014. Some of the leading players that adopted this strategy include GlaxoSmithKline, plc. (U.K.), Merck and Company (U.S.), Novartis AG (Switzerland), and Sanofi Pasteur (France). Regulatory approvals accounted for the second-largest share of the overall growth strategies adopted by players in the market.
Browse related reports
Veterinary Vaccines & Animal Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html
Opportunity Analysis of H1N1 (swine flu) Vaccination Market
http://www.marketsandmarkets.com/Market-Reports/influenza-vaccines-market-159.html
About MarketsandMarkets
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]
Visit MarketsandMarkets Blog http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
SOURCE MarketsandMarkets